Table 13.6e
Immunosuppression Use for Maintenance
Prior to Discharge, 1997 to 2006
Recipients with Heart-Lung Transplants
| 40 |
31 |
34 |
33 |
21 |
22 |
17 |
35 |
29 |
24 |
| 38 |
29 |
33 |
33 |
21 |
22 |
17 |
35 |
29 |
24 |
| 94.7% |
89.7% |
100.0% |
100.0% |
100.0% |
100.0% |
94.1% |
100.0% |
100.0% |
100.0% |
| 94.7% |
89.7% |
100.0% |
100.0% |
100.0% |
100.0% |
94.1% |
100.0% |
100.0% |
100.0% |
| 71.1% |
72.4% |
66.7% |
81.8% |
71.4% |
59.1% |
47.1% |
37.1% |
48.3% |
29.2% |
| 7.9% |
10.3% |
18.2% |
6.1% |
9.5% |
13.6% |
5.9% |
0.0% |
0.0% |
0.0% |
| 63.2% |
62.1% |
48.5% |
72.7% |
57.1% |
40.9% |
23.5% |
22.9% |
31.0% |
12.5% |
| 0.0% |
0.0% |
0.0% |
3.0% |
4.8% |
4.5% |
17.6% |
14.3% |
13.8% |
16.7% |
| 0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
3.4% |
0.0% |
| 34.2% |
27.6% |
39.4% |
27.3% |
23.8% |
45.5% |
52.9% |
65.7% |
55.2% |
75.0% |
| 34.2% |
27.6% |
39.4% |
27.3% |
23.8% |
45.5% |
52.9% |
65.7% |
55.2% |
75.0% |
| 94.7% |
82.8% |
84.8% |
93.9% |
95.2% |
95.5% |
82.4% |
82.9% |
96.6% |
91.7% |
| 18.4% |
34.5% |
48.5% |
45.5% |
52.4% |
40.9% |
29.4% |
54.3% |
55.2% |
70.8% |
| 76.3% |
48.3% |
36.4% |
48.5% |
42.9% |
54.5% |
52.9% |
28.6% |
41.4% |
20.8% |
| 0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
5.9% |
2.9% |
0.0% |
0.0% |
| 0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
5.9% |
2.9% |
0.0% |
0.0% |
| 0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |